Search now, choose a product area below or scroll down to see our full range.
1-10 / 735
Amorphous dispersion is a strategy used to improve the solubility and oral bioavailability of poorly water-soluble pharmaceutical compounds.
Chiral separations is a process used to separate a racemic mixture of two isomers into their constituent enantiomers.
By forming cocrystals drug developers can modify the physical properties of an API while preserving the benefits of a crystalline solid form.
Crystallisation development is an essential step utilised throughout the production of pharmaceutical drugs.
Crystallography is the detailed analysis of crystal structures.
Assess the performance of novel crystalline forms, design-appropriate salt and cocrystal screens and investigate alternative drug delivery routes.
Polymorph screening is the identification and characterisation of all relevant polymorphic forms of a pharmaceutical compound.
Salt screening is a crucial step in modern drug development, as the presence of various salt forms can increase the dissolution rate and oral bioavailability of an API.
Cas number: 5908-99-6
CAS Number: 1310584-14-5